{"resourceId":"openscientist-medrxiv-preprint-failure-modes-hypothesis-rejection-20261027","versions":[{"version":"external-746933e6694b1700656200a0ec34642fb8dda1c78962dda27581be376307d648","resource":{"id":"openscientist-medrxiv-preprint-failure-modes-hypothesis-rejection-20261027","title":"OpenScientist preprint reports strong but imperfect performance, including incomplete hypothesis rejection in randomized controls","organization":"OpenScientist authors (C-BRAIN; Lawrence Berkeley National Laboratory and collaborators)","sector":"Higher education / biomedical research","geography":"United States","publishedAt":"2026-03-18","publicationDate":"2026-03-18","eventDate":null,"sourceName":"medRxiv","sourceLabel":"OpenScientist preprint (medRxiv 2026.03.15.26348338v1, full text)","sourceUrl":"https://www.medrxiv.org/content/10.64898/2026.03.15.26348338v1.full","evidenceClass":"academic-research","outcomeClass":"mixed","topics":["developers-agents","knowledge-work","governance-procurement"],"finding":"The preprint behind NVIDIA's claims evaluates OpenScientist on four featured clinical case studies (plus three further use cases) and reports failure modes: no cross-iteration multiple-testing correction and inconsistent hypothesis prioritization, domain-science errors in some skills, final reports generated from summaries rather than the data, and incomplete hypothesis rejection in negative-control and randomized analyses, where some hypotheses stayed supported after true signal was removed.","sledRelevance":"Newly relevant because NVIDIA's Oct 27 post leans on these case studies. Universities adopting agentic research tools need documented safeguards against false positives before outputs inform publications or grants.","evidence":"Non-peer-reviewed preprint with expert-evaluated case studies and validation experiments; authors are affiliated with the consortium and tool developers.","architectureImplications":"Agent architecture where reports are generated from summaries can compound errors; authors propose direct data access, statistical safeguards and domain validation layers.","governanceImplications":"Research integrity offices should require multiple-testing correction, negative controls and human statistical review for agent-generated findings.","securityPrivacyImplications":"No specific security finding; provenance and citation tracking gaps affect auditability.","caveats":"Not peer reviewed; authors include C-BRAIN's director and the OpenScientist lead, so it is not independent of the claims it supports.","streamIds":["nvidia"],"roles":{"sales":"The preprint is a credibility asset: it shows the tool's developers documenting their own failure modes. Use it with research leaders to argue that agentic research tools need validation programs, not just deployment. A university buying or adopting such tools will face research-integrity questions about false positives, so propose an engagement that designs negative-control tests and review workflows. Do not represent the preprint as independent or peer-reviewed. Its authors include consortium leaders, which is itself a reason to fund local validation.","engineering":"Engineering should build in the safeguards the authors propose: family-wise or false-discovery-rate tracking across iterations, consistency checks across skills and scoring formulas, domain validation layers for analysis code, and report generation that reads data and provenance directly instead of summaries. Run negative-control and randomized-label tests on every pipeline, since the preprint found hypotheses surviving after true signal was removed. Log analysis code, data versions and citations for each agent run so reviewers can trace any conclusion back to evidence.","delivery":"Delivery should embed a research-integrity checkpoint: no agent-generated finding goes into a manuscript or grant without statistician review and a passing negative-control test. Work with the research integrity office to write guidance on disclosing AI agent use. Acceptance criteria for any pilot should include false-positive rates on randomized controls. Train researchers on the documented failure modes. Track how often reviewers overturn agent conclusions as an ongoing quality metric."},"roleDetails":{"sales":{"customerProblem":"Agentic research tools can produce plausible but false findings.","stakeholders":["Research integrity officer","Vice president for research","Biostatistics core lead"],"discoveryQuestions":["How do you validate AI-generated analyses?","Do you require negative controls?"],"valueHypothesis":"A validation program reduces integrity risk while preserving speed benefits.","potentialEngagement":"Agentic-research validation framework design.","unsupportedClaims":["Not peer reviewed.","Not independent of the consortium."]},"engineering":{"fit":"Labs piloting agentic analysis tools.","architectureIntegration":"Agent pipeline with FDR tracking, domain validation and direct-data reporting.","prerequisites":["Negative-control datasets","Provenance logging"],"constraints":["Incomplete hypothesis rejection","Summaries-based reporting"],"security":"Ensure auditability via logged code, data and citations.","proofOfValue":["False-positive rate on randomized controls","Reviewer agreement rate"]},"delivery":{"work":"Add integrity checkpoints and negative-control testing.","dependencies":["Biostatistics support","Integrity office guidance"],"ownership":"Research integrity office with PIs.","skillsAdoption":"Train researchers on failure modes.","governanceCheckpoints":["Statistician review before publication"],"acceptanceCriteria":["Negative-control pass","Disclosure guidance published"],"risks":["False findings published","Reviewer bottleneck"]}},"retrievedAt":"2026-10-28T03:04:23Z","enrichedAt":"2026-10-28T03:12:33Z","enrichmentBasis":"retrieved source","accessibilityWorkforceImplications":"Researchers need statistical literacy to catch agent errors; training should accompany tool access.","procurementImplications":"Institutions should ask agent-tool providers for negative-control validation results and FDR safeguards.","operatingModelImplications":"Agent outputs should pass through a human validation step before use.","sourceVerification":{"openedUrl":"https://www.medrxiv.org/content/10.64898/2026.03.15.26348338v1.full","referenceExcerpt":"validation experiments showed that it does not yet consistently achieve complete hypothesis rejection when underlying biological structure is removed.","promptVersion":"sled-research-v4.0","model":null,"basis":"agent-reported inspection"}}}]}